Advertisment

Seropositive

covaxin_vs_covishield_Covid_Vaccine
Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients than those who took the i...
Advertisment
Subscribe